Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

Table of Contents

September 1, 1990; Volume 31,Issue 9
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Alazraki, Naomi P.

    1. You have access
      Lines from the President Nuclear Medicine's Best but Toughest Times
      Naomi P. Alazraki
      Journal of Nuclear Medicine September 1, 1990, 31 (9) 26A-30A;
  2. Alonso, Carmen

    1. You have access
      Radioimmune Imaging of Bone Marrow in Patients with Suspected Bone Metastases from Primary Breast Cancer
      Carlos M. Duncker, Ignasi Carrió, Lluis Berná, Montserrat Estorch, Carmen Alonso, Belén Ojeda, Remei Blanco, Josep-Ramón Germá and Victoria Ortega
      Journal of Nuclear Medicine September 1, 1990, 31 (9) 1450-1455;
  3. Atcher, Robert W.

    1. You have access
      Iodine-125-NRLU-10 Kinetic Studies and Bismuth-212-NRLU-10 Toxicity in LS174T Multicell Spheroids
      Virginia K. Langmuir, Robert W. Atcher, John J. Hines and Martin W. Brechbiel
      Journal of Nuclear Medicine September 1, 1990, 31 (9) 1527-1533;
  4. Baker, Richmond J.

    1. You have access
      Kit Preparation of Technetium-99m-Mercaptoacetyltriglycine: Analysis, Biodistribution and Comparison with Technetium-99m-DTPA in Patients with Impaired Renal Function
      Kym M. Bannister, Stan Penglis, Johan C. Bellen, Richmond J. Baker and Barry E. Chatterton
      Journal of Nuclear Medicine September 1, 1990, 31 (9) 1568-1573;
  5. Bakker, Willem H.

    1. You have access
      Receptor Scintigraphy with a Radioiodinated Somatostatin Analogue: Radiolabeling, Purification, Biologic Activity, and In Vivo Application in Animals
      Willem H. Bakker, Eric P. Krenning, Wout A. Breeman, Jan W. Koper, Peter P. Kooij, Jean-Claude Reubi, Jan G. Klijn, Theo J. Visser, Roel Docter and Steven W. Lamberts
      Journal of Nuclear Medicine September 1, 1990, 31 (9) 1501-1509;
  6. Bannister, Kym M.

    1. You have access
      Kit Preparation of Technetium-99m-Mercaptoacetyltriglycine: Analysis, Biodistribution and Comparison with Technetium-99m-DTPA in Patients with Impaired Renal Function
      Kym M. Bannister, Stan Penglis, Johan C. Bellen, Richmond J. Baker and Barry E. Chatterton
      Journal of Nuclear Medicine September 1, 1990, 31 (9) 1568-1573;
  7. Bellen, Johan C.

    1. You have access
      Kit Preparation of Technetium-99m-Mercaptoacetyltriglycine: Analysis, Biodistribution and Comparison with Technetium-99m-DTPA in Patients with Impaired Renal Function
      Kym M. Bannister, Stan Penglis, Johan C. Bellen, Richmond J. Baker and Barry E. Chatterton
      Journal of Nuclear Medicine September 1, 1990, 31 (9) 1568-1573;
  8. Berna, Lluis

    1. You have access
      Radioimmune Imaging of Bone Marrow in Patients with Suspected Bone Metastases from Primary Breast Cancer
      Carlos M. Duncker, Ignasi Carrió, Lluis Berná, Montserrat Estorch, Carmen Alonso, Belén Ojeda, Remei Blanco, Josep-Ramón Germá and Victoria Ortega
      Journal of Nuclear Medicine September 1, 1990, 31 (9) 1450-1455;
  9. Blanco, Remei

    1. You have access
      Radioimmune Imaging of Bone Marrow in Patients with Suspected Bone Metastases from Primary Breast Cancer
      Carlos M. Duncker, Ignasi Carrió, Lluis Berná, Montserrat Estorch, Carmen Alonso, Belén Ojeda, Remei Blanco, Josep-Ramón Germá and Victoria Ortega
      Journal of Nuclear Medicine September 1, 1990, 31 (9) 1450-1455;
  10. Brechbiel, Martin W.

    1. You have access
      Iodine-125-NRLU-10 Kinetic Studies and Bismuth-212-NRLU-10 Toxicity in LS174T Multicell Spheroids
      Virginia K. Langmuir, Robert W. Atcher, John J. Hines and Martin W. Brechbiel
      Journal of Nuclear Medicine September 1, 1990, 31 (9) 1527-1533;
« Previous (Pages : 1 2 3 4 5 6 ... 14) Next »
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine
Vol. 31, Issue 9
September 1, 1990
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Advertising (PDF)
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
  • Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine
  • Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
  • Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
  • High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections
More...
SNMMI

© 2025 SNMMI

Powered by HighWire